Výsledky vyhledávání

Akademický článek

Controversial Flow Cytometry Monitoring of a Relapse Case of Pediatric T Cell Acute Lymphoblastic Leukemia: A Case Report

Autor: Delia Codruţa Popa, Andreea Şerbănică, Radu Obrisca, Ionut Şerbănică, Letiţia Radu, Cristina Jercan, Andra Marcu, Ana Bica, Minodora Asan, Mădălina Petran, Mihaela Dragomir, Cerasela Jardan, Valeria Ţică, Anca Gheorghe, Irina Stoian, Daniel Coriu, Anca Coliţă, Andrei Coliţă

Publikováno v: Frontiers in Medicine, Vol 9 (2022)

Acute lymphoblastic leukemia (ALL) is the most frequent childhood cancer, with 80–85% represented by B cell ALL and only 15% by T cell ALL. T Cell ALL (T-ALL) carries a more reserved prognosis compared to B Cell ALL (B-ALL) with regard to response

Externí odkaz: https://doaj.org/article/20273a428980449b87811819bec5c3b1

Zobrazit plný text záznamu

Akademický článek

2014-2017 RETROSPECTIVE STUDY ON THE ANALYSIS OF CAUSES OF DEATH, OTHER THAN DISEASE PROGRESSION, IN CHILDREN DIAGNOSED WITH ACUTE LYMPHOBLASTIC LEUKAEMIA – EXPERIENCE OF THE PAEDIATRIC DEPARTMENT OF FUNDENI CLINICAL INSTITUTE

Autor: Andreea Serbanica, Letitia Radu, Cristina Jercan, Andra Beldiman, Ana Bica, Petruta Vasilache, Minodora Asan, Oana Grigoras, Anca Gheorghe, Codruta Popa, Cerasela Jardan, Constantin Arion, Anca Colita

Publikováno v: Romanian Journal of Pediatrics, Vol 67, Iss 4, Pp 177-184 (2018)

Introduction. Acute lymphoblastic leukemia (ALL) is the most common form of cancer in the pediatric population (1). The survival rate has increased in recent years due to the continuous adjustment of therapeutic protocols (2). Despite all the efforts

Externí odkaz: https://doaj.org/article/06ff43d0f41e4253acde1224b1b8e1e8

Zobrazit plný text záznamu

Akademický článek

Day 15 and Day 33 Minimal Residual Disease Assessment for Acute Lymphoblastic Leukemia Patients Treated According to the BFM ALL IC 2009 Protocol: Single-Center Experience of 133 Cases

Autor: Letitia-Elena Radu, Andrei Colita, Sergiu Pasca, Ciprian Tomuleasa, Codruta Popa, Catalin Serban, Anca Gheorghe, Andreea Serbanica, Cristina Jercan, Andra Marcu, Ana Bica, Patric Teodorescu, Catalin Constantinescu, Bobe Petrushev, Minodora Asan, Cerasela Jardan, Mihaela Dragomir, Alina Tanase, Anca Colita

Publikováno v: Frontiers in Oncology, Vol 10 (2020)

Introduction: Childhood acute lymphoblastic leukemia (ALL) is a hematologic malignancy characterized by the acquisition of several genetic lesions in the lymphoid progenitors with subsequent proliferation advantage and lack of maturation. Along the y

Externí odkaz: https://doaj.org/article/19bdc832da5d43a380225e67120599af

Zobrazit plný text záznamu

ORAL MUCOSITIS – SIGNIFICANT COMPLICATION OF PEDIATRIC PATIENTS UNDERGOING HEMATOPOIETIC STEM CELL TRANSPLANTATION

Autor: Ana Bica, Oana Otilia Niculiță, Pharmacy, Bucharest, Romania, Andra Marcu, Anca Coliță, Cristina Jercan, Roxana Elena Doncu

Publikováno v: Romanian Journal of Pediatrics, Vol 70, Iss 2, Pp 148-155 (2021)

Introduction. The prognosis of pediatric solid tumors has improved in recent years through the use of multimodal treatment – chemotherapy, local control (surgery and radiotherapy) and hematopoietic stem cell transplantation (HSCT) for high-risk for

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::215df3519468c999bfe58e051b7bd67c
https://doi.org/10.37897/rjp.2021.2.10

Zobrazit plný text záznamu

Pharmacokinetics of Posaconazole Oral Suspension in Children Dosed According to Body Surface Area

Autor: Raf Mols, Kim Vanstraelen, Ana Bica, Pieter Vermeersch, Isabel Spriet, Patrick Augustijns, Pieter Annaert, Anca Colita, Nele Peersman

Publikováno v: Pediatric Infectious Disease Journal. 35:183-188

Antifungal prophylaxis remains challenging in immunocompromised children as no clear consensus has yet been reached about which drug to be used. Posaconazole has a broad spectrum of activity, a favorable safety profile and excellent prophylactic acti

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dd7293119c2986ac3e24b3924699a667
https://doi.org/10.1097/inf.0000000000000963

Zobrazit plný text záznamu

P191 Evaluation of minimum residual disease in paediatric patients with acute lymphoblastic leukaemia in terms of individualised therapy and prognosis

Autor: Cristina Zaharia, Cerasela Jardan, Mirela Asan, Andreea Serbanica, Petruta Vasilache, Anca Colita, Anca Gheorghe, Ana Bica, Andra Beldiman, Letitia Elena Radu, Mihaela Safta

Publikováno v: Posters.

Background Monitoring minimal residual (MRD) in paediatric pacients with ALL is the most important way to detect relapse, to individualised the treatment (selection of the intensity and the duration of chemotherapy), to evaluate the early response on

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::7c24bf2d76d74b781092e4321c3f0461
https://doi.org/10.1136/archdischild-2017-313273.279

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání